After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
VRNA belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Verona Pharma Plc ADR is $7.87B. A total of 1.38 million shares were traded on the day, compared to an average of 1.42M shares.
In the most recent transaction, DAVID ZACCARDELLI bought 50,000 shares of VRNA for 86.78 per share on Jun 11 ’25. In a previous transaction on Jun 11 ’25, MARK HAHN bought 50,000 shares at 86.78 per share.
Among the insiders who sold shares, Hahn Mark W disposed of 204,864 shares on May 29 ’25 at a per-share price of $9.33. This resulted in the Chief Financial Officer holding 12,678,992 shares of VRNA after the transaction. In another insider transaction, Hahn Mark W sold 162,704 shares at $9.30 per share on May 28 ’25. Company shares held by the Chief Financial Officer now total 12,883,856.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, VRNA has a high of $92.98 and a low of $13.60.
As of this writing, VRNA has an earnings estimate of $0.39 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of $0.39 per share and a lower estimate of $0.39.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. VRNA’s latest balance sheet shows that the firm has $148.38M in Cash & Short Term Investments as of fiscal 2021. There were $5.81M in debt and $33.42M in liabilities at the time. Its Book Value Per Share was $2.66, while its Total Shareholder’s Equity was $148.00M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
